Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 139

1.

The Innate Part of the Adaptive Immune System.

Hillion S, Arleevskaya MI, Blanco P, Bordron A, Brooks WH, Cesbron JY, Kaveri S, Vivier E, Renaudineau Y.

Clin Rev Allergy Immunol. 2019 Jun 1. doi: 10.1007/s12016-019-08740-1. [Epub ahead of print] Review.

PMID:
31154567
2.

Toll-Like Receptors, Infections, and Rheumatoid Arthritis.

Arleevskaya MI, Larionova RV, Brooks WH, Bettacchioli E, Renaudineau Y.

Clin Rev Allergy Immunol. 2019 May 29. doi: 10.1007/s12016-019-08742-z. [Epub ahead of print] Review.

PMID:
31144208
3.

Editorial: Shaping of Human Immune System and Metabolic Processes by Viruses and Microorganisms.

Arleevskaya MI, Aminov R, Brooks WH, Manukyan G, Renaudineau Y.

Front Microbiol. 2019 Apr 17;10:816. doi: 10.3389/fmicb.2019.00816. eCollection 2019. No abstract available.

4.

Apoptotic resistance in chronic lymphocytic leukemia and therapeutic perspectives.

Bagacean C, Tomuleasa C, Tempescul A, Grewal R, Brooks WH, Berthou C, Renaudineau Y.

Crit Rev Clin Lab Sci. 2019 Aug;56(5):321-332. doi: 10.1080/10408363.2019.1600468. Epub 2019 May 6.

PMID:
30935269
5.
6.

Involvement of X Chromosome Short Arm in Autoimmune Diseases: Comment on the Article by Sharma et al.

Brooks WH.

Arthritis Rheumatol. 2018 Apr;70(4):625-626. doi: 10.1002/art.40411. Epub 2018 Feb 18. No abstract available.

7.

Viral Impact in Autoimmune Diseases: Expanding the "X Chromosome-Nucleolus Nexus" Hypothesis.

Brooks WH.

Front Immunol. 2017 Nov 28;8:1657. doi: 10.3389/fimmu.2017.01657. eCollection 2017.

8.

Memory B Cells and Response to Abatacept in Rheumatoid Arthritis.

Gazeau P, Alegria GC, Devauchelle-Pensec V, Jamin C, Lemerle J, Bendaoud B, Brooks WH, Saraux A, Cornec D, Renaudineau Y.

Clin Rev Allergy Immunol. 2017 Oct;53(2):166-176. doi: 10.1007/s12016-017-8603-x.

PMID:
28477078
9.

Molecular Dynamics Simulations of Membrane-Bound STIM1 to Investigate Conformational Changes during STIM1 Activation upon Calcium Release.

Mukherjee S, Karolak A, Debant M, Buscaglia P, Renaudineau Y, Mignen O, Guida WC, Brooks WH.

J Chem Inf Model. 2017 Feb 27;57(2):335-344. doi: 10.1021/acs.jcim.6b00475. Epub 2017 Feb 15.

PMID:
28151650
10.

Epigenetic modifications in salivary glands from patients with Sjögren's syndrome affect cytokeratin 19 expression.

Konsta OD, Charras A, Le Dantec C, Kapsogeorgeou E, Bordron A, Brooks WH, Tzioufas AG, Pers JO, Renaudineau Y.

Bull Group Int Rech Sci Stomatol Odontol. 2016 Jun 28;53(1):e01.

PMID:
27352422
11.

A Review of Autoimmune Disease Hypotheses with Introduction of the "Nucleolus" Hypothesis.

Brooks WH.

Clin Rev Allergy Immunol. 2017 Jun;52(3):333-350. doi: 10.1007/s12016-016-8567-2. Review.

PMID:
27324247
12.

An in silico Approach Reveals Associations between Genetic and Epigenetic Factors within Regulatory Elements in B Cells from Primary Sjögren's Syndrome Patients.

Konsta OD, Le Dantec C, Charras A, Brooks WH, Arleevskaya MI, Bordron A, Renaudineau Y.

Front Immunol. 2015 Aug 26;6:437. doi: 10.3389/fimmu.2015.00437. eCollection 2015.

13.

Human endogenous retrovirus group E and its involvement in diseases.

Le Dantec C, Vallet S, Brooks WH, Renaudineau Y.

Viruses. 2015 Mar 16;7(3):1238-57. doi: 10.3390/v7031238. Review.

14.

Epigenetics and autoimmune diseases: the X chromosome-nucleolus nexus.

Brooks WH, Renaudineau Y.

Front Genet. 2015 Feb 16;6:22. doi: 10.3389/fgene.2015.00022. eCollection 2015.

15.

Intravascular frequency-domain optical coherence tomography assessment of carotid artery disease in symptomatic and asymptomatic patients.

Jones MR, Attizzani GF, Given CA 2nd, Brooks WH, Ganocy SJ, Ramsey CN, Fujino Y, Bezerra HG, Costa MA.

JACC Cardiovasc Interv. 2014 Jun;7(6):674-84. doi: 10.1016/j.jcin.2014.01.163.

16.

Optical coherence tomography of the intracranial vasculature and Wingspan stent in a patient.

Given CA 2nd, Ramsey CN 3rd, Attizzani GF, Jones MR, Brooks WH, Bezerra HG, Costa MA.

J Neurointerv Surg. 2015 Jun;7(6):e22. doi: 10.1136/neurintsurg-2014-011114.rep. Epub 2014 May 20.

PMID:
24847090
17.

Optical coherence tomography of the intracranial vasculature and Wingspan stent in a patient.

Given CA 2nd, Ramsey CN 3rd, Attizzani GF, Jones MR, Brooks WH, Bezerra HG, Costa MA.

BMJ Case Rep. 2014 May 16;2014. pii: bcr2014011114. doi: 10.1136/bcr-2014-011114.

18.

The contribution of epigenetics in Sjögren's Syndrome.

Konsta OD, Thabet Y, Le Dantec C, Brooks WH, Tzioufas AG, Pers JO, Renaudineau Y.

Front Genet. 2014 Apr 3;5:71. doi: 10.3389/fgene.2014.00071. eCollection 2014. Review.

19.

Stromal interaction molecules as important therapeutic targets in diseases with dysregulated calcium flux.

Mukherjee S, Brooks WH.

Biochim Biophys Acta. 2014 Oct;1843(10):2307-14. doi: 10.1016/j.bbamcr.2014.03.019. Epub 2014 Mar 25. Review.

20.

Carotid angioplasty with stenting versus endarterectomy: 10-year randomized trial in a community hospital.

Brooks WH, Jones MR, Gisler P, McClure RR, Coleman TC, Breathitt L, Spear C.

JACC Cardiovasc Interv. 2014 Feb;7(2):163-168. doi: 10.1016/j.jcin.2013.09.010.

21.

DNA methylation modulates HRES1/p28 expression in B cells from patients with Lupus.

Fali T, Le Dantec C, Thabet Y, Jousse S, Hanrotel C, Youinou P, Brooks WH, Perl A, Renaudineau Y.

Autoimmunity. 2014 Jun;47(4):265-71. doi: 10.3109/08916934.2013.826207. Epub 2013 Oct 14.

22.

Increased polyamines alter chromatin and stabilize autoantigens in autoimmune diseases.

Brooks WH.

Front Immunol. 2013 Apr 17;4:91. doi: 10.3389/fimmu.2013.00091. eCollection 2013.

23.

Frequency-domain optical coherence tomography assessment of human carotid atherosclerosis using saline flush for blood clearance without balloon occlusion.

Given CA 2nd, Attizzani GF, Jones MR, Ramsey CN 3rd, Brooks WH, Costa MA, Bezerra HG.

AJNR Am J Neuroradiol. 2013 Jul;34(7):1414-8. doi: 10.3174/ajnr.A3411. Epub 2013 Feb 7.

24.

Frequency-domain optical coherence tomography assessment of very late vascular response after carotid stent implantation.

Attizzani GF, Jones MR, Given CA 2nd, Brooks WH, Bezerra HG, Costa MA.

J Vasc Surg. 2013 Jul;58(1):201-4. doi: 10.1016/j.jvs.2012.11.038. Epub 2013 Jan 26.

25.

Virtual target screening: validation using kinase inhibitors.

Santiago DN, Pevzner Y, Durand AA, Tran M, Scheerer RR, Daniel K, Sung SS, Woodcock HL, Guida WC, Brooks WH.

J Chem Inf Model. 2012 Aug 27;52(8):2192-203. doi: 10.1021/ci300073m. Epub 2012 Jul 23.

26.

Intravascular frequency-domain optical coherence tomography assessment of atherosclerosis and stent-vessel interactions in human carotid arteries.

Jones MR, Attizzani GF, Given CA 2nd, Brooks WH, Costa MA, Bezerra HG.

AJNR Am J Neuroradiol. 2012 Sep;33(8):1494-501. doi: 10.3174/ajnr.A3016. Epub 2012 Mar 15.

27.

Epigenetics and Sjögren's syndrome.

Le Dantec C, Varin MM, Brooks WH, Pers JO, Youinou P, Renaudineau Y.

Curr Pharm Biotechnol. 2012 Aug;13(10):2046-53. Review.

28.

Mechanisms and pathophysiology of autoimmune disease.

Brooks WH.

Clin Rev Allergy Immunol. 2012 Feb;42(1):1-4. doi: 10.1007/s12016-011-8298-3.

PMID:
22187334
29.

Autoimmune diseases and polyamines.

Brooks WH.

Clin Rev Allergy Immunol. 2012 Feb;42(1):58-70. doi: 10.1007/s12016-011-8289-4. Review.

PMID:
22116709
30.

Epigenetic alterations and autoimmune disease.

Renaudineau Y, Beauvillard D, Padelli M, Brooks WH, Youinou P.

J Dev Orig Health Dis. 2011 Oct;2(5):258-64. doi: 10.1017/S2040174411000353.

PMID:
25141262
31.

The significance of chirality in drug design and development.

Brooks WH, Guida WC, Daniel KG.

Curr Top Med Chem. 2011;11(7):760-70. Review.

32.

Shp2 protein tyrosine phosphatase inhibitor activity of estramustine phosphate and its triterpenoid analogs.

Scott LM, Chen L, Daniel KG, Brooks WH, Guida WC, Lawrence HR, Sebti SM, Lawrence NJ, Wu J.

Bioorg Med Chem Lett. 2011 Jan 15;21(2):730-3. doi: 10.1016/j.bmcl.2010.11.117. Epub 2010 Dec 4.

33.

Epigenetics in autoimmune disorders: highlights of the 10th Sjögren's syndrome symposium.

Lu Q, Renaudineau Y, Cha S, Ilei G, Brooks WH, Selmi C, Tzioufas A, Pers JO, Bombardieri S, Gershwin ME, Gay S, Youinou P.

Autoimmun Rev. 2010 Jul;9(9):627-30. doi: 10.1016/j.autrev.2010.05.011. Epub 2010 May 7. Review.

34.

Epigenetics and autoimmunity.

Brooks WH, Le Dantec C, Pers JO, Youinou P, Renaudineau Y.

J Autoimmun. 2010 May;34(3):J207-19. doi: 10.1016/j.jaut.2009.12.006. Epub 2010 Jan 6. Review.

PMID:
20053532
35.

X chromosome inactivation and autoimmunity.

Brooks WH.

Clin Rev Allergy Immunol. 2010 Aug;39(1):20-9. doi: 10.1007/s12016-009-8167-5. Review.

PMID:
19653135
36.

New insights into the design of inhibitors of human S-adenosylmethionine decarboxylase: studies of adenine C8 substitution in structural analogues of S-adenosylmethionine.

McCloskey DE, Bale S, Secrist JA 3rd, Tiwari A, Moss TH 3rd, Valiyaveettil J, Brooks WH, Guida WC, Pegg AE, Ealick SE.

J Med Chem. 2009 Mar 12;52(5):1388-407. doi: 10.1021/jm801126a.

37.

Acute cerebral rescue during carotid artery stenting: a stroke of good fortune?

Jones MR, Brooks WH.

Catheter Cardiovasc Interv. 2009 May 1;73(6):749-52. doi: 10.1002/ccd.21911.

PMID:
19198005
38.

Computational validation of the importance of absolute stereochemistry in virtual screening.

Brooks WH, Daniel KG, Sung SS, Guida WC.

J Chem Inf Model. 2008 Mar;48(3):639-45. doi: 10.1021/ci700358r. Epub 2008 Feb 12.

PMID:
18266348
39.

In silico chemical library screening and experimental validation of a novel 9-aminoacridine based lead-inhibitor of human S-adenosylmethionine decarboxylase.

Brooks WH, McCloskey DE, Daniel KG, Ealick SE, Secrist JA 3rd, Waud WR, Pegg AE, Guida WC.

J Chem Inf Model. 2007 Sep-Oct;47(5):1897-905. Epub 2007 Aug 4.

PMID:
17676832
40.
41.

Subcellular mobility of the calpain/calpastatin network: an organelle transient.

Hood JL, Brooks WH, Roszman TL.

Bioessays. 2006 Aug;28(8):850-9. Review.

PMID:
16927317
42.

GMFM 1 year after continuous intrathecal baclofen infusion.

Krach LE, Kriel RL, Gilmartin RC, Swift DM, Storrs BB, Abbott R, Ward JD, Bloom KK, Brooks WH, Madsen JR, McLaughlin JF, Nadell JM.

Pediatr Rehabil. 2005 Jul-Sep;8(3):207-13.

PMID:
16087555
43.
44.

Differential compartmentalization of the calpain/calpastatin network with the endoplasmic reticulum and Golgi apparatus.

Hood JL, Brooks WH, Roszman TL.

J Biol Chem. 2004 Oct 8;279(41):43126-35. Epub 2004 Aug 9.

45.

Hip status in cerebral palsy after one year of continuous intrathecal baclofen infusion.

Krach LE, Kriel RL, Gilmartin RC, Swift DM, Storrs BB, Abbott R, Ward JD, Bloom KK, Brooks WH, Madsen JR, McLaughlin JF, Nadell JM.

Pediatr Neurol. 2004 Mar;30(3):163-8.

PMID:
15033197
46.

Carotid angioplasty and stenting versus carotid endarterectomy for treatment of asymptomatic carotid stenosis: a randomized trial in a community hospital.

Brooks WH, McClure RR, Jones MR, Coleman TL, Breathitt L.

Neurosurgery. 2004 Feb;54(2):318-24; discussion 324-5.

PMID:
14744277
47.

Association of the calpain/calpastatin network with subcellular organelles.

Hood JL, Logan BB, Sinai AP, Brooks WH, Roszman TL.

Biochem Biophys Res Commun. 2003 Oct 31;310(4):1200-12.

PMID:
14559243
48.
49.

Autoantibodies from an SLE patient immunostain the Barr body.

Brooks WH, Satoh M, Hong B, Reeves WH, Yang TP.

Cytogenet Genome Res. 2002;97(1-2):28-31.

PMID:
12438734
50.

Calpain II colocalizes with detergent-insoluble rafts on human and Jurkat T-cells.

Morford LA, Forrest K, Logan B, Overstreet LK, Goebel J, Brooks WH, Roszman TL.

Biochem Biophys Res Commun. 2002 Jul 12;295(2):540-6.

PMID:
12150984

Supplemental Content

Loading ...
Support Center